Abstract
In a previous study, CETP inhibitory peptide (3 kDa) was isolated from hog plasma. The peptide, synthesized chemically according to the amino acid sequence of the 3-kDa peptide (designated P28), showed CETP inhibitory activity both in vitro and in vivo [Cho et al. (1998) Biochim. Biophys. Acta 1391, 133–144]. We report herein further unique features of P28 when it was associated with the cholesteryl ester (CE)-donor and-acceptor lipoproteins. Lipoprotein substrates with P28 present in both HDL (as a CE-donor) and LDL (as a CE-acceptor) served as poor substrates, with CE-transfer activity decreased up to 60% compared to normal substrates without P28. P28 was found to be located in HDL fractions of hog plasma and showed the same electromobility as that visualized by PAGE on 7% polyacrylamide gel under nondenaturing conditions. Addition of apolipoprotein A-1 (apoA-1) or apoB antibody to a normal CE-transfer mixture did not alter CE-transfer activity. However, addition of apoA-1 or −B antibody to a CETP-inhibition mixture decreased the inhibitory activity of P28 by ca. 20%. Western blot analysis revealed that P28 was associated only with human and hog HDL among several lipoproteins purified from human, hog, and rabbit. CFTP-inhibition assays with various lipoprotein substrates revealed that P28 exhibited substrate-specific inhibitory activity. The inhibitory activity of P28 was highly dependent on the type of lipoprotein substrate (whether CE-donor or-acceptor); P28 inhibited CE transfer from HDL to LDL, but it did not inhibit CE transfer from HDL to HDL.
Similar content being viewed by others
Abbreviations
- ApoA-1:
-
apolipoprotein A-1
- apoB:
-
apolipoprotein B
- BCA:
-
bicinchoninic acid
- CE:
-
cholesteryl ester
- HDLR :
-
reconstituted HDL
- LDLR :
-
reconstituted LDL
- LTIP:
-
lipid transfer inhibitor protein
- PVDF:
-
polyvinyldifluoride
References
Jarnagin, A.S., Kohr, W., and Fielding, C. (1987) Isolation and Specificity of a Mr 74,000 Cholesteryl Ester Transfer Protein from Human Plasma, Proc. Natl. Acad. Sci. USA 84, 1854–1857.
Hesler, C.B., Swenson, T.L., and Tall, A.R. (1987) Purification and Characterization of a Human Plasma Cholesteryl Ester Transfer Protein, J. Biol. Chem. 262, 2275–2282.
Morton, R.E., and Zilversmit, D.B. (1983) Inter-relationship of Lipids Transferred by the Lipid-Transfer Protein Isolated from Human Lipoprotein-Deficient Plasma, J. Biol. Chem. 258, 11751–11757.
Inazu, A., Brown, M.L., Hesler, C.B., Agellon, L.B., Koizumi, J., Takata, K., Maruhama, Y., Mabuchi, H., and Tall, A.R. (1990) Increased High-Density Lipoprotein Caused by a Common Cholesteryl Ester Transfer Protein Gene Mutation, N. Engl. J. Med. 323, 1234–1238.
Whitlock, M.E., Swenson, T.L., Ramakrishnan, R., Leonard, M.T., Marcel, Y.L., Milne, R.W., and Tall, A.R. (1989) Monoclonal Antibody Inhibition of Cholesteryl Ester Transfer Protein Activity in the Rabbit: Effects on Lipoprotein Composition and High Density Lipoprotein Cholesteryl Ester Metabolism, J. Clin. Invest. 84, 129–137.
Abbey, M., and Calvert, G.D. (1989) Effects of Blocking Plasma Lipid Transfer Protein Activity in the Rabbit, Biochim. Biophys. Acta 1003, 20–29.
Gaynor, B.J., Sand, T., Clark, R.W., Aiello, R.J., Bamberger, M.J., and Moberly, J.B. (1994) Inhibition of Cholesteryl Ester Transfer Protein Activity in Hamsters Alters HDL Lipid Composition, Atherosclerosis 110, 101–109.
Ha, Y.C., Chang, L.B.F., and Barter, P.J. (1985) Effects of Injecting Exogenous Lipid Transfer Protein into Rats, Biochim. Biophys. Acta 833, 203–210.
Quig, D.W., and Zilversmit, D.B. (1986) Disappearance and Effects of Exogenous Lipid Transfer Activity in Rats, Biochim. Biophys. Acta 879, 171–178.
Ha, Y.C., and Barter, P.J. (1986) Effects of Sucrose Feeding and Injection of Lipid Transfer Protein on Rat Plasma Lipoproteins, Comp. Biochem. Physiol. B 83, 463–466.
Gavish, D., Oschry, Y., and Eisenberg, S. (1987) In vivo Conversion of Human HDL3 to HDL2 and ApoE-rich HDL1 in the Rat: Effects of Lipid Transfer Protein, J. Lipid Res. 28, 257–267.
Groener, J.E.M., van Gent, T., and van Tol, A. (1989) Effect of Lipid Transfer Protein on Plasma Lipids, Apolipoproteins and Metabolism of High-Density Lipoprotein Cholesteryl Ester in the Rat, Biochim. Biophys. Acta 1002, 93–100.
Marotti, K.R., Castle, C.K., Murray, R.W., Rehberg, E.F., Polites, H.G., and Melchior, G.W. (1992) The Role of Cholesteryl Ester Transfer Protein in Primate Apolipoprotein A-I Metabolism: Insights from Studies with Transgenic Mice, Arterioscler. Thromb. 12, 736–744.
Marotti, K.R., Castle, C.K., Boyle, T.P., Lin, A.H., Murray, R.W., and Melchior, G.W. (1993) Severe Atherosclerosis in Transgenic Mice Expressing Simian Cholesteryl Ester Transfer Protein, Nature 364, 73–75.
Rittershaus, C.W., Miller, D.P., Thomas, L.J., Picard, M.D., Honan, C.M., Emmett, C.D., Pettey, C.L., Adari, H., Hammond, R.A., Beattie, D.T. et al. (2000) Vaccine-Induced Antibodies Inhibiti CETP Activity in vivo and Reduce Aortic Lesions in a Rabbit Model of Atherosclerosis, Arterioscler. Thromb. Vasc. Biol. 20, 2106–2112.
de Grooth, G.J., Kuivenhoven, J.A., Stalenhoef, A.F.H., de Graff, J., Zwinderman, A.H., Posma, J.L., van Tol, A., and Kastelein, J.J.P. (2002) Efficacy and Safety of a Novel Cholesteryl Ester Transfer Protein Inhibitor. JTT-705, in Humans: A Randomized Phase II Dose-Response Study, Circulation 105, 2159–2165.
Barter, P.J., Hopkins, G.J., Gorjatschko, L., and Jones, M.E. (1982) A Unified Model of Esterified Cholesterol Exchanges Between Human Plasma Lipoproteins, Atherosclerosis 44, 27–40.
Ihm, J., Quinn, D.M., Busch, S.J., Chataing, B., and Harmony, J.A.K. (1982) Kinetics of Plasma Protein-Catalyzed Exchange of Phosphatidylcholine and Cholesteryl Ester Between Plasma Lipoproteins, J. Lipid Res. 23, 1328–1341.
Barter, P.J., and Jones, M.E. (1980) Kinetic Studies of the Transfer of Esterified Cholesterol Between Human Plasma low and High Density Lipoproteins, J. Lipid Res. 21, 238–249.
Tall, A.R. (1993) Plasma Cholesteryl Ester Transfer Protein, J. Lipid Res. 34, 1255–1274.
Wang, X., Driscoll, D.M., and Morton, R.E. (1999) Molecular Cloning and Expression of Lipid Transfer Inhibitor Protein Reveals Its Identity with Apolipoprotein F, J. Biol. Chem. 274, 1814–1820.
Kushwaha, R.S., Hasan, S.Q., McGill, H.C., Jr., Getz, G.S., Dunham, R.G., and Kanda, P. (1993) Characterization of Cholesteryl Ester Transfer Protein Inhibitor from Plasma of Baboons (Papio sp.), J. Lipid Res. 34, 1285–1297.
Cho, K.H., Lee, J.Y., Choi, M.S., Cho, J.M., Lim, J.S., and Park, Y.B. (1998) A Peptide from Hog Plasma That Inhibits Human Cholesteryl Ester Transfer Protein, Biochim. Biophys. Acta 1391, 133–144.
Havel, R.J., Eder, H.A., and Bragdon, J.H. (1955) The Distribution and Chemical Composition of Ultracentrifugally Separated Lipoproteins in Human Serum, J. Clin. Invest. 34, 1345–1353.
Chen, C.H., and Albers, J.J. (1982) Characterization of Proteoliposomes Containing Apoplipoprotein A-I: A New Substrate for the Measurement of Lecithin: Cholesterol Acyltransferase Activity, J. Lipid Res. 23, 680–691.
Albers, J.J., Tollefson, J.H., Cheng, C.-H., and Steinmetz, A. (1984) Isolation and Characterization of Human Plasma Lipid Transfer Proteins, Arteriosclerosis 4, 49–58.
Batzri, S., and Korn, E.D. (1973) Single Bilayer Liposomes Prepared Without Sonication, Biochim. Biophys. Acta 298, 1015–1019.
Allen, T.M., Romans, A.Y., Kercret, H., and Segrest, J.P. (1980) Detergent Removal During Membrane Reconstitution, Biochim. Biophys. Acta 601, 328–342.
Dunbar, B.S., and Schwoebel, E.D. (1990) Preparation of Polyclonal Antibodies, Methods Enzymol 182: 663–670.
Towbin, H., and Gordon, J. (1984) Immunoblotting and Dot Immunobinding—Current Status and Outlook, J. Immunol. Methods 72, 313–340.
Pattnaik, N.M., and Zilversmit, D.B. (1979) Interaction of Cholesteryl Ester Exchange Protein with Human Plasma Lipoproteins and Phospholipid Vesicles, J. Biol. Chem. 254, 2782–2786.
Morton, R.E. (1985) Binding of Plasma-Derived Lipid Transfer Protein to Lipoprotein Substrates. The Role of Binding in the Lipid Transfer Process, J. Biol. Chem. 260, 12593–12599.
Sammett, D., and Tall, A.R. (1985) Mechanisms of Enhancement of Cholesteryl Ester Transfer Protein Activity by Lipolysis, J. Biol. Chem. 260, 6687–6697.
Morton, R.E., and Zilversmit, D.B. (1981) A Plasma Inhibitor of Triglyceride and Cholesteryl Ester Transfer Activities, J. Biol. Chem. 256, 11992–11995.
Wang, S., Deng, L., Brown, M.L., Agellon, L.B., and Tall, A.R. (1991) Structure-Function Studies of Human Cholesteryl Ester Transfer Protein by Linker Insertion Scanning Mutagenesis, Biochemistry 30, 3484–3490.
Author information
Authors and Affiliations
Corresponding author
About this article
Cite this article
Cho, KH., Lee, JY., Choi, MS. et al. Interaction of CETP inhibitory peptide and lipoprotein substrates in cholesteryl ester transfer assay: Relationship between association properties and inhibitory activities. Lipids 37, 641–646 (2002). https://doi.org/10.1007/s11745-002-0944-9
Received:
Revised:
Accepted:
Issue Date:
DOI: https://doi.org/10.1007/s11745-002-0944-9